We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Highly Sensitive Laser Scanning to Advance Antibody Discovery

By LabMedica International staff writers
Posted on 31 Aug 2010
A new framework for highly sensitive laser scanning is now available to cell biologists and other life scientists working in the field of antibody discovery.

The new "Mirrorball” system is manufactured by TTP LabTech (Royston, United Kingdom), who maintain that it addresses one of the currently unmet needs of laser scanning instrumentation – that of high sensitivity. More...
In addition, Mirrorball is advertised as the first laser scanning microplate cytometer to offer simultaneous laser scanning.

Mirrorball operates at high sensitivity that enables detection of proteins that are only found at low abundance. This ensures that the instrument is perfectly suited to mix-and-read assays for hybridoma screening and cell-surface receptor expression. Simultaneous laser scanning results in superior multiplexing and analytical capabilities that enable robust and rapid data generation. Label-free detection takes place concurrently with fluorescence measurements resulting in improved object recognition and fewer false negatives, based on individual object count. Minimal autofluorescence due to proprietary low loss optics and red 640 nm laser excitation leads to a high signal-to-noise ratio and guarantees robust data generation.

Dr. Wayne Bowen, CSO at TTP LabTech, said, "Mirrorball is TTP LabTech's response to requests from scientists for novel technologies in antibody discovery. We have listened, developed, and now delivered a high sensitivity microplate cytometer for fluorescence cellular screening.”

Related Links:

TTP LabTech




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Automated Clinical Chemistry Analyzer
Envoy 500+
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.